• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双插入式(2,2':6',2''-三联吡啶)铂(II)配合物的合成、表征及细胞毒性

The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.

作者信息

Harper Benjamin W J, Aldrich-Wright Janice R

机构信息

Nanoscale Organisation and Dynamics Group, School of Science and Health, University of Western Sydney, Locked Bag 1797, Penrith South DC, 2751, NSW, Australia.

出版信息

Dalton Trans. 2015 Jan 7;44(1):87-96. doi: 10.1039/c4dt02773f.

DOI:10.1039/c4dt02773f
PMID:25407567
Abstract

Dinuclear (2,2':6',2''-terpyridine)platinum(II) (PtTerpy) complexes were synthesised by tethering either thiol or pyridine based linkers. All intermediates and resulting complexes were characterised using a combination of (1)H and (195)Pt NMR, two-dimensional (1)H correlation spectroscopy (NOSY/COSY), two-dimensional (1)H/(195)Pt heteronuclear multiple bond correlation spectroscopy (HMQC), elemental analysis and electrospray ionisation mass spectrometry (ESI-MS). The cytotoxicity of the complexes was determined against human A2780 ovarian carcinoma cells and its cisplatin-resistant sub-line A2780cis, as well as L1210 murine leukemia cells.

摘要

通过连接基于硫醇或吡啶的连接体合成了双核(2,2':6',2''-三联吡啶)铂(II)(PtTerpy)配合物。所有中间体和所得配合物均通过¹H和¹⁹⁵Pt核磁共振、二维¹H相关光谱(核Overhauser效应光谱/化学位移相关光谱)、二维¹H/¹⁹⁵Pt异核多键相关光谱、元素分析和电喷雾电离质谱进行表征。测定了这些配合物对人A2780卵巢癌细胞及其顺铂耐药亚系A2780cis以及L1210小鼠白血病细胞的细胞毒性。

相似文献

1
The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.双插入式(2,2':6',2''-三联吡啶)铂(II)配合物的合成、表征及细胞毒性
Dalton Trans. 2015 Jan 7;44(1):87-96. doi: 10.1039/c4dt02773f.
2
Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.环戊烷羧酸酰肼铂(II)配合物的合成、细胞毒性及抗肿瘤活性
Biol Chem. 1999 Nov;380(11):1287-94. doi: 10.1515/BC.1999.164.
3
Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.2,2':6',2''-三联吡啶铂(II)配合物对人卵巢癌的细胞毒性
J Med Chem. 1999 Aug 12;42(16):3167-74. doi: 10.1021/jm991053y.
4
Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.合成具有体内抗肿瘤活性和独特体外细胞毒性特征的唑桥联双核铂(II)配合物。
Metallomics. 2013 May;5(5):461-8. doi: 10.1039/c3mt00040k. Epub 2013 Apr 23.
5
Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.反式-双-(2-羟基吡啶)二氯合铂(II)的合成及其在人卵巢肿瘤模型中的活性。
Anticancer Res. 2012 Jan;32(1):135-40.
6
The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.五种含功能化吡啶的新型反式铂(IV)配合物的合成、光谱、X射线表征及体外细胞毒性活性测试结果
Eur J Med Chem. 2012 Sep;55:214-9. doi: 10.1016/j.ejmech.2012.07.019. Epub 2012 Jul 22.
7
In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands.三种新型双核铂(II)配合物与 4′-取代-2,2′:6′,2″-三联吡啶配体的体外和体内抗肿瘤活性。
Eur J Med Chem. 2019 May 15;170:195-202. doi: 10.1016/j.ejmech.2019.03.014. Epub 2019 Mar 9.
8
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.轴向和赤道配体对反式-1R,2R-二氨基环己烷铂(IV)配合物抗肿瘤活性的调节作用。
Anticancer Drug Des. 1994 Apr;9(2):139-51.
9
Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.抗肿瘤奥沙利铂/顺铂对接双核铂配合物的制备
Biomed Pharmacother. 2005 Jun;59(5):224-9. doi: 10.1016/j.biopha.2004.06.006.
10
Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.具有潜在细胞毒性的混合配体铂(II)恶二唑啉配合物的设计、合成、表征和化学反应性。
Dalton Trans. 2010 Sep 7;39(33):7747-59. doi: 10.1039/c0dt00360c. Epub 2010 Jul 26.

引用本文的文献

1
A Targeted Radiotheranostic Agent for Glioblastoma: [Cu]Cu-NOTA-TP-c(RGDfK).一种用于胶质母细胞瘤的靶向放射诊疗剂:[铜]铜- NOTA - TP - c(RGDfK)
Brain Sci. 2025 Aug 7;15(8):844. doi: 10.3390/brainsci15080844.
2
The arylbipyridine platinum (II) complex increases the level of ROS and induces lipid peroxidation in glioblastoma cells.芳基联吡啶铂(II)配合物可提高胶质母细胞瘤细胞中活性氧水平并诱导脂质过氧化。
Biometals. 2025 Feb;38(1):185-202. doi: 10.1007/s10534-024-00646-6. Epub 2024 Oct 14.
3
Design, Synthesis, and Cytotoxicity Assessment of [Cu]Cu-NOTA-Terpyridine Platinum Conjugate: A Novel Chemoradiotherapeutic Agent with Flexible Linker.
[Cu]Cu-氮杂环三乙酸-三联吡啶铂共轭物的设计、合成及细胞毒性评估:一种具有柔性连接体的新型放化疗药物
Nanomaterials (Basel). 2021 Aug 24;11(9):2154. doi: 10.3390/nano11092154.
4
Influence of Ligand and Nuclearity on the Cytotoxicity of Cyclometallated C^N^C Platinum(II) Complexes.配体和核数对环金属化 C^N^C 铂(II)配合物细胞毒性的影响。
Chemistry. 2020 Nov 20;26(65):14938-14946. doi: 10.1002/chem.202002517. Epub 2020 Oct 15.
5
Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity.具有多种DNA相互作用模式和表皮生长因子受体(EGFR)抑制活性的铂(II)三联吡啶抗癌配合物
Front Chem. 2020 Apr 28;8:210. doi: 10.3389/fchem.2020.00210. eCollection 2020.
6
Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.基于咪唑菲咯啉桥联配体的双核铂(II)配合物作为潜在的抗癌剂:合成、表征和体外细胞毒性研究。
J Biol Inorg Chem. 2019 May;24(3):405-418. doi: 10.1007/s00775-019-01656-3. Epub 2019 Apr 3.